Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Atrial Fibrillation Devices Market?

In recent years, the market size for atrial fibrillation devices has noticeably expanded. The market, worth $7.69 billion in 2024, is predicted to hit $8.60 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.8%. Factors like an increase in the older population, a surge in demand for minimally invasive cardiovascular techniques, a rise in government initiatives and the growing provision of telecardiology services are considered to be behind this historic growth period.

Expectation for the atrial fibrillation devices market’s size is that there will be fast expansion in the near future. The market is projected to escalate up to $13.28 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%. The projected growth during the forecast period can be due to factors such as rising healthcare expenses, an increasing count of multi-specialty hospitals, higher inclination towards advanced treatment alternatives, amplified regulatory backing for device clearances, and a surge in demand for minimally invasive surgical procedures. Major emerging trends during the forecast period encompass technological advancements, progress in remote monitoring devices, the incorporation of artificial intelligence in diagnostics, developments in non-invasive ablation systems, as well as advancements in mapping and imaging technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp

Which Factor Is Shaping The Future Of The Atrial Fibrillation Devices Market?

The escalating prevalence of cardiovascular diseases is set to stimulate growth in the atrial fibrillation device market. Disorders that affect the heart and blood vessels, like heart attacks, strokes, and hypertension, come under the umbrella of cardiovascular diseases. The rise in such diseases can be linked to a worldwide increase in obesity and diabetes, combined with the adoption of inactive lifestyles and unhealthy eating practices on a widespread scale. Atrial fibrillation (AFib) devices are instrumental in managing cardiovascular diseases since they can identify, monitor, and treat abnormal heart rhythms often linked to or caused by underlying heart conditions. For example, the American Heart Association, a US-based public health organization, reported in June 2024 that high blood pressure is projected to rise from 51.2% to 61.0%. Consequently, the number of people diagnosed with cardiovascular diseases is expected to increase from 128 million in 2020 to over 184 million by 2050. This rise in cardiovascular diseases is fueling the growth of the atrial fibrillation device market.

What Is The Segment-Wise Breakdown Of The Atrial Fibrillation Devices Market?

The atrial fibrillation devices market covered in this report is segmented –

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices

2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products

3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies

4) By Distribution Channel: Direct Sales, Distributors, Online Sales

5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors

2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors

3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

Which Trends Are Redefining The Future Landscape Of The Atrial Fibrillation Devices Industry?

Leading businesses in the atrial fibrillation devices market are exploiting advancements in technologies such as patient-oriented clinical decision support tools. These technologies elevate diagnostic precision, customize treatment strategies, and upgrade overall patient repercussions. They are digital innovations that assist medical professionals in shaping treatment choices through the analysis of unique patient data. For example, GE HealthCare Technologies Inc., an American medical technology firm, unveiled CardioVisio for Atrial Fibrillation in August 2023. This digital clinical decision support tool is engineered to streamline clinician procedures and boost precise care for patients suffering from atrial fibrillation. It lets healthcare providers observe the progression of AFib, encompassing past diagnoses, treatments, medications, and linked ailments. The platform provides guideline-based therapy suggestions, which could reduce diagnostic inaccuracies and simplify clinical decision-making. CardioVisio compiles scattered patient data in an understandable format, lessening the load on healthcare staff, and empowering quicker, personalized, and more efficient management of atrial fibrillation.

Which Companies Hold The Largest Market Share In The Atrial Fibrillation Devices Sector?

Major companies operating in the atrial fibrillation devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips N.V., Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co. Ltd., Japan Lifeline Co. Ltd., Microlife Corporation, AliveCor Inc., CardioFocus Inc., Imricor Medical Systems Inc., Kardium Inc., Stereotaxis Inc., Volta Medical, Synaptic Medical Corporation, Osypka AG, CathRx Ltd., BIOTRONIK SE & Co. KG, EP Solutions SA, CardiacSense Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report

How Does Regional Performance Compare Across The Atrial Fibrillation Devices Industry?

North America was the largest region in the atrial fibrillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model